Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice
Xiaomeng Hu(Sana Biotechnology (United States)), Sonja Schrepfer(University of California, San Francisco)
Cited by 81
Related Papers
Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques
|Nature Biotechnology|2023|145
Hypoimmune induced pluripotent stem cell–derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice
|Proceedings of the National Academy of Sciences|2021|53